Phase 3 T Cell Clinical Trials
11 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–11 of 11 trials
Recruiting
Phase 3
Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone
Giant Cell Tumor of Bone
St. Louis University120 enrolled16 locationsNCT03295981
Recruiting
Phase 3
Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL
Mycosis FungoidesCutaneous T Cell LymphomaCTCL+1 more
Soligenix80 enrolled17 locationsNCT06470451
Recruiting
Phase 3
Golidocitinib Versus Placebo as Maintenance Therapy in PTCL Patients With Response (CR/PR) After First-Line Chemotherapy
Peripheral T Cell Lymphoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine68 enrolled1 locationNCT07414758
Recruiting
Phase 2Phase 3
A Clinical Trial of Cidabenamine Plus Azacitidine to Prevent Post-Transplant Progression in High-Risk Peripheral T-Cell Lymphoma
Peripheral T Cell Lymphoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine40 enrolled1 locationNCT07389616
Recruiting
Phase 3
Abatacept for the Treatment of Giant Cell Arteritis
Giant Cell Arteritis
University of Pennsylvania78 enrolled9 locationsNCT04474847
Recruiting
Phase 3
A Randomized, Double-blind, Multicenter Phase III Study of XNW5004 Tablets in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma
Relapsed/Refractory Peripheral T Cell Lymphoma
Evopoint Biosciences Inc.120 enrolled1 locationNCT06776952
Recruiting
Phase 3
To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL
Peripheral T Cell Lymphoma
Acrotech Biopharma Inc.504 enrolled69 locationsNCT06072131
Recruiting
Phase 2Phase 3
Newly-diagnosed Pediatric T-cell ALL Protocol
Acute Lymphoblastic LeukemiaChildhood Leukemia, Acute LymphoblasticT Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
Institute of Hematology & Blood Diseases Hospital, China610 enrolled27 locationsNCT06855810
Not Yet Recruiting
Phase 2Phase 3
Safety and Efficacy of FSD202 for the treatment of chronic pain associated with idiopathic MCAS (MCAD)
Chronic Widespread Musculoskeletal Nociplastic Pain Associated with Idiopathic Mast Cell Activation Syndrome (Disorder)
FSD Pharma Australia Pty Ltd.60 enrolled1 locationACTRN12625000665437
Recruiting
Phase 3
A Multicenter, Phase 3, Randomized Trial of Sequencial Chemoradiotherapy with or Without Toripalimab (PD-1 Antibody) in Newly Diagnosed Early-Stage Extranodal Natural Killer/T Cell Lymphoma, Nasal Type (ENKTL)
NK/T Cell Lymphoma Nos
Sun Yat-sen University207 enrolled1 locationNCT04365036
Recruiting
Phase 3
Haplo-cord HCT vs. Haplo-HCT for T-ALL Patients
Acute T Cell Lymphoblastic LeukemiaHaploidentical Hematopoietic Stem Cell TransplantationCord Blood
The First Affiliated Hospital of Soochow University146 enrolled1 locationNCT06381817